AVIEW Lung Texture

Coreline Soft

Lung Texture defines the fibrotic area of the lungs in 6 patterns and automatically generates a report by analyzing the location and distribution. Quantitative analysis help with difficult reading cases and reduce deviations from different reading techniques for diagnosis.

6 Patterns of ILD: Honeycomb, Reticular, GGO, Normal, Consolidation and Emphysema. ILA analysis are based on Fleischner society guidance, aimed at reducing the chances of missing abnormal findings that may develop into ILD. Fibrotic lesions and non-fibrotic lesions provide information on lung lobes with fibrotic lesions of 5% or more.

Product specifications

Information source: Vendor
Last updated: March 16, 2023

General
Product name	AVIEW Lung Texture
Company	Coreline Soft
Subspeciality	Chest
Modality	CT
Disease targeted	Interstitial Lung Disease (ILD), Interstitial Lung Abnormalities (ILA), Pneumonia
Key-features	Fibrotic area localization, classification, and distribution, lung and lobe segmentation, pneumonia score
Suggested use	During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion
Data characteristics
Population	All adult chest CT, not intended for pediatric population
Input	Non-contrast, high dose, standard dose, low dose
Input format	DICOM
Output	Overlay masks, radiology report, batch images
Output format	DICOM Secondary Capture, DICOM Structured Report
Technology
Integration	Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased
Deployment	Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis	Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time	1 - 10 minutes
Certification
CE	Certified, Class IIa , MDD
FDA	Not applicable
Market presence
On market since	11-2017
Distribution channels	RMS Medical Devices
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model	Pay-per-use, Subscription, One-off payment
Based on	Number of users, Number of analyses
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers